NCT04056221

Brief Summary

Sjögren's syndrome (SS) is a multisystemic chronic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands, resulting in salivary and lacrimal glands hypofunction, with symptoms of dry eyes and mouth. Xerostomia and xerophthalmia present profound negative impact on patients' quality of life, especially due to difficulties in swallowing, dysarthria, dysgeusia, halitosis and burning tongue, discomfort and visual disturbances that lead to daily activities difficulty such as driving or reading. Although some drugs may improve symptoms and prevent SS complications, they can cause significant adverse effects and even fail to relieve symptoms. Integrative and complementary techniques have become a therapeutic option for SS patients. Scientific evidence has supported the efficacy of acupuncture in relieving symptoms of xerostomia and xerophthalmia. Due to the lack of well-controlled and standardized clinical studies, this study aimed to conduct a randomized and controlled trial to determine the efficacy of acupuncture as a therapeutic option for SS patients' symptoms relief.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2019

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2022

Completed
Last Updated

March 14, 2023

Status Verified

March 1, 2023

Enrollment Period

2.8 years

First QC Date

March 17, 2019

Last Update Submit

March 11, 2023

Conditions

Keywords

Sjogren's syndromexerostomiaxerophthalmiaacupuncture

Outcome Measures

Primary Outcomes (5)

  • Changes from baseline Oral Health Impact Profile (OHIP-14) score at 2 and 3 months.

    Instrument of data collection which comprises of 14 questions with two questions each under seven domains. The domains include; functional limitation,physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap. Responses to the questions are based on a Likert scale which ranged from 0- "never" to 4- "always".

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline Xerostomia Inventory score at at 2 and 3 months.

    It is an 11-item questionnaire that covers both experiential and behavioral aspects of xerostomia. Scores to the 11 items are summated, providing a single score representing the subjective severity of xerostomia.

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline The Challacombe scale at at 2 and 3 months.

    The purpose of this scale is to be able to visually identify and quantify whether your patient has xerostomia (dry mouth)

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) at 2 and 3 months.

    There is a 0-10 numerical scale for each of the four domains, dryness, discomfort (including pain), global fatigue and mental fatigue

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline Ocular Surface Disease Index (OSDI) at 2 and 3 months.

    This 12-item questionnaire assesses dry eye symptoms and the effects it has on vision-related function in the past week of the patient's life. The questionnaire has 3 subscales: ocular symptoms, vision-related function, and environmental triggers. Patients rate their responses on a 0 to 4 scale with 0 corresponding to "none of the time" and 4 corresponding to "all of the time."

    Before (baseline), immediately after and 1 month after acupuncture treatment.

Secondary Outcomes (3)

  • Changes from baseline whole unstimulated salivary flow rate at 2 and 3 months.

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline Schirmer test scores at 2 and 3 months.

    Before (baseline), immediately after and 1 month after acupuncture treatment.

  • Changes from baseline ocular surface staining at 2 and 3 months.

    Before (baseline), immediately after and 1 month after acupuncture treatment.

Study Arms (2)

acupuncture

EXPERIMENTAL

Acupuncture at the selected points.

Other: Acupuncture

Sham acupuncture

SHAM COMPARATOR

Similar appearance to conventional acupuncture, however, without needles skin penetration.

Other: Sham acupuncture

Interventions

Acupuncture stimulation was done manually, using single-use acupuncture needles that will be inserted on the selected acupoints (R6, E6, E2, Ig4, VC24, TA23, B2) once a week,for 8 weeks, 20 minutes sessions with 12 weeks of follow up.

acupuncture

The sham acupuncture consists of needles that achieves no skin penetration and are holden on the points by an adhesive pad.

Sham acupuncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥ 18 years old, both genres, who consent to participate of the study
  • Patients who were diagnosed with SJ according to the criteria of the American College of Rheumatology and the European League against Rheumatism

You may not qualify if:

  • Patients who have undergone head and neck radiation therapy;
  • Patients with a history of neoplasias and salivary gland infections;
  • Patients with acquired immunodeficiency virus infection, sarcoidosis, viral hepatitis, diabetes mellitus and smokers;
  • Patients with inability to undergo total saliva collection by established techniques;
  • Patients who can not attend regular acupuncture sessions;
  • Patients who had a change in the dosage of medications in use within 6 weeks before the start of the study.
  • Patients who received acupuncture therapy up to 6 weeks prior to the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Dentistry of Ribeirão Preto, University of São Paulo

Ribeirão Preto, São Paulo, 14040-904, Brazil

Location

Related Publications (6)

  • Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008 Jul 7;8:37. doi: 10.1186/1472-6882-8-37.

    PMID: 18606019BACKGROUND
  • Jiang Q, Zhang H, Pang R, Chen J, Liu Z, Zhou X. Acupuncture for Primary Sjogren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial. BMC Complement Altern Med. 2017 Jan 19;17(1):61. doi: 10.1186/s12906-017-1559-9.

    PMID: 28103850BACKGROUND
  • Hackett KL, Deane KH, Strassheim V, Deary V, Rapley T, Newton JL, Ng WF. A systematic review of non-pharmacological interventions for primary Sjogren's syndrome. Rheumatology (Oxford). 2015 Nov;54(11):2025-32. doi: 10.1093/rheumatology/kev227. Epub 2015 Jun 30.

    PMID: 26135587BACKGROUND
  • Assy Z, Brand HS. A systematic review of the effects of acupuncture on xerostomia and hyposalivation. BMC Complement Altern Med. 2018 Feb 13;18(1):57. doi: 10.1186/s12906-018-2124-x.

    PMID: 29439690BACKGROUND
  • Hu WL, Wu PC, Pan LY, Yu HJ, Pan CC, Hung YC. Effect of laser acupuncture on dry eye: A study protocol for a 2-center randomized controlled trial. Medicine (Baltimore). 2018 Jun;97(22):e10875. doi: 10.1097/MD.0000000000010875.

    PMID: 29851803BACKGROUND
  • Kim BH, Kim MH, Kang SH, Nam HJ. Optimizing acupuncture treatment for dry eye syndrome: a systematic review. BMC Complement Altern Med. 2018 May 3;18(1):145. doi: 10.1186/s12906-018-2202-0.

    PMID: 29724255BACKGROUND

MeSH Terms

Conditions

Sjogren's SyndromeXerostomiaXerophthalmia

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesConjunctival Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Jaciara M Gomes-Silva, DDS, PhD

    University of São Paulo, Ribeirão Preto, SP, Brazil.

    STUDY CHAIR
  • Maria Cristina Borsato, DDS, PhD

    University of São Paulo, Ribeirão Preto, SP, Brazil.

    STUDY CHAIR
  • Eduardo Melani Rocha, DDS, PhD

    University of São Paulo, Ribeirão Preto, SP, Brazil.

    STUDY CHAIR
  • Fabiola R Oliveira, DDS, PhD

    University of São Paulo, Ribeirão Preto, SP, Brazil.

    STUDY CHAIR
  • Maria da Conceição P Saraiva, DDS, PhD

    University of São Paulo, Ribeirão Preto, SP, Brazil.

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both patients and investigators who will assess the outcomes have no knowledge of the interventions assigned to individual participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Sjogren syndrome's patients will be randomly assigned to either acupuncture (experimental group) at the selected acupoints (R6, E6,E2, Ig4, VC24, TA23, B2) or sham acupuncture (control group), where the needles do not penetrate the skin into non acupuncture points, for 8 weeks, 20 minutes sessions with 12 weeks of follow up.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Oral Diagnosis

Study Record Dates

First Submitted

March 17, 2019

First Posted

August 14, 2019

Study Start

February 18, 2019

Primary Completion

December 6, 2021

Study Completion

October 10, 2022

Last Updated

March 14, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

No plan to make individual participant data available to other researchers.

Locations